These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 760482)

  • 1. Efficacy of a new oral agent (tocainide) in the acute treatment of refractory ventricular arrhythmias.
    Ryan W; Engler R; LeWinter M; Karliner JS
    Am J Cardiol; 1979 Feb; 43(2):285-91. PubMed ID: 760482
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tocainide for refractory symptomatic ventricular arrhythmias.
    Podrid PJ; Lown B
    Am J Cardiol; 1982 Apr; 49(5):1279-86. PubMed ID: 6801955
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term tocainide therapy for ventricular arrhythmias.
    Winkle RA; Meffin PJ; Harrison DC
    Circulation; 1978 May; 57(5):1008-16. PubMed ID: 639200
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tocainide: a new oral antiarrhythmic.
    Hasegawa GR
    Drug Intell Clin Pharm; 1985; 19(7-8):514-7. PubMed ID: 3928308
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative efficacy and safety of oral tocainide and quinidine for benign and potentially lethal ventricular arrhythmias.
    Morganroth J; Oshrain C; Steele PP
    Am J Cardiol; 1985 Oct; 56(10):581-5. PubMed ID: 3931448
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and safety of oral tocainide in refractory ventricular arrhythmia: a preliminary report on an open label study.
    Mahapatra RK; Mahapatra D
    Angiology; 1986 Apr; 37(4):285-93. PubMed ID: 2424347
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chronic tocainide therapy for refractory high-grade ventricular arrhythmias.
    Haffajee CI; Sacks GM; Alpert JS; Howe JP; Ockene IS; Paraskos JA; Dalen JE
    Clin Cardiol; 1983 Feb; 6(2):72-8. PubMed ID: 6403267
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tocainide: a new oral antiarrhythmic agent.
    Kutalek SP; Morganroth J; Horowitz LN
    Ann Intern Med; 1985 Sep; 103(3):387-91. PubMed ID: 3927807
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Double-blind randomized comparison of intravenous tocainide versus lidocaine in the treatment of chronic ventricular arrhythmias.
    Mohiuddin SM; Hilleman DE; Mooss AN; Esterbrooks D; Sketch MH; Stengel LA; Butler ML
    Am Heart J; 1987 Aug; 114(2):296-302. PubMed ID: 3111238
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and safety of intravenous tocainide compared with intravenous lidocaine for acute ventricular arrhythmias immediately after cardiac surgery.
    Morganroth J; Panidis IP; Harley S; Johnson J; Smith E; MacVaugh H
    Am J Cardiol; 1984 Dec; 54(10):1253-8. PubMed ID: 6439023
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tocainide. A review of its pharmacological properties and therapeutic efficacy.
    Holmes B; Brogden RN; Heel RC; Speight TM; Avery GS
    Drugs; 1983 Aug; 26(2):93-123. PubMed ID: 6411445
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New antiarrhythmic drugs: tocainide, mexiletine, flecainide, encainide, and amiodarone.
    Kreeger RW; Hammill SC
    Mayo Clin Proc; 1987 Nov; 62(11):1033-50. PubMed ID: 3118116
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tocainide plus quinidine for treatment of ventricular arrhythmias.
    Barbey JT; Thompson KA; Echt DS; Woosley RL; Roden DM
    Am J Cardiol; 1988 Mar; 61(8):570-3. PubMed ID: 3125737
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Randomized double-blind study of intravenous tocainide versus lidocaine for suppression of ventricular arrhythmias after cardiac surgery.
    Manolis AS; Smith E; Payne D; Rastegar H; Cleveland R; Estes NA
    Clin Cardiol; 1990 Mar; 13(3):177-81. PubMed ID: 2108835
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chemistry, pharmacology, antiarrhythmic efficacy and adverse effects of tocainide hydrochloride, an orally active structural analog of lidocaine.
    Alpert JS; Haffajee CI; Young MD
    Pharmacotherapy; 1983; 3(6):316-23. PubMed ID: 6419205
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A review of the uses and limitations of tocainide--a class IB antiarrhythmic agent.
    Morganroth J; Nestico PF; Horowitz LN
    Am Heart J; 1985 Oct; 110(4):856-63. PubMed ID: 3931446
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combination antiarrhythmic therapy for management of malignant ventricular arrhythmia.
    Patt MV; Grossbard CL; Graboys TB; Lown B
    Am J Cardiol; 1988 Nov; 62(14):18I-21I. PubMed ID: 2461071
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combination of tocainide and quinidine for better tolerance and additive effects in patients with coronary artery disease.
    Kim SG; Mercando AD; Fisher JD
    J Am Coll Cardiol; 1987 Jun; 9(6):1369-74. PubMed ID: 3108345
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tocainide therapy for refractory ventricular arrhythmias.
    Roden DM; Roden DM; Reele SB; Reele SB; Higgins SB; Higgins SB; Carr RK; Carr RK; Smith RF; Smith RF; Oates JA; Oates JA; Woosley RL; Woosley RL
    Am Heart J; 1980 Jul; 100(1):15-22. PubMed ID: 6770666
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative study of tocainide and lidocaine in patients admitted for suspected acute myocardial infarction.
    Rehnqvist N; Erhardt L; Ericsson CG; Olsson G; Svensson G; Sjögren A
    Acta Med Scand; 1983; 214(1):21-7. PubMed ID: 6414252
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.